Establishment of a nomogram that predicts the risk of heart failure in hemodialysis patients

Jie Luo1, Zhangru Rui1, Yun He1

  • 1YAN'AN Hospital of Kunming City, Kunming 650051, China.

Insights

A new nomogram predicts heart failure hospitalization risk in hemodialysis patients. This tool aids clinicians in identifying high-risk individuals for improved management and reduced hospitalizations.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Informatics

Background:

  • Chronic kidney disease (CKD) is a growing global health concern, projected to be the fifth leading cause of death by 2040.
  • Cardiovascular disease (CVD), especially heart failure (HF), is a major complication for patients undergoing hemodialysis.
  • Effective risk stratification is crucial for managing HF in this vulnerable population.

Purpose of the Study:

  • To develop and validate a predictive nomogram for heart failure hospitalization risk in hemodialysis patients.
  • To provide a clinical decision-making tool for early identification of high-risk individuals.
  • To potentially improve patient outcomes and reduce healthcare burden associated with HF hospitalizations.

Main Methods:

  • Retrospective analysis of data from 196 hemodialysis patients.
  • Identification of significant predictors using univariate and multivariate logistic regression.
  • Development of a nomogram incorporating age, diabetes, dialysis duration, left ventricular mass index (LVMI), albumin (ALB), and ejection fraction (EF).

Main Results:

  • The developed nomogram demonstrated good predictive discrimination (AUC = 0.728).
  • The model showed excellent calibration, with no significant lack of fit (Hosmer-Lemeshow test, P = 0.463).
  • Decision curve analysis confirmed the nomogram's clinical utility and applicability across various risk thresholds.

Conclusions:

  • The validated nomogram serves as a valuable tool for predicting heart failure hospitalization risk in hemodialysis patients.
  • Clinicians can utilize this nomogram to identify at-risk individuals, enabling targeted interventions.
  • Implementation of this tool may lead to improved management strategies and a reduction in HF-related hospitalizations within the hemodialysis population.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
273
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
225
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30